- Filed
- Nov 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 12.26M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 12.09M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 10.65M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 10.58M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $69.91M |
| Capex | Q3 2025 · Sep 30, 2024 | $37.86M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $79.92M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $40.12M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $1.07B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $977M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $16.87M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $16.58M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $24.63M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $22.82M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $551.87M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $467.79M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $147.45M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $174.8M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $1.32B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.26B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $112.15M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $118.27M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $2.41B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $2.36B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.13 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.95 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$19.25 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$10.39 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.13 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.95 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$19.25 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$10.39 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $13.16M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $45.28M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $12.42M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $41.37M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$1.58M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$11.49M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$204.94M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$109.96M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $38.14M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $109.49M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $28.25M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $88.05M |
| Revenue | Q3 2025 · Sep 30, 2025 | $146.88M |
| Revenue | Q3 2025 · Sep 30, 2025 | $419.8M |
| Revenue | Q3 2025 · Sep 30, 2024 | $102.42M |
| Revenue | Q3 2025 · Sep 30, 2024 | $322.6M |